Colgate-Palmolive
NYSE: CL
Stock price
88.1 USD
(+16.55%) 5 years
Financial Performance
5Y price score: 21
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 45.1%
%
ㅤ
By default your notes are visible only to you.
74.5
52-week range
99.3
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
5.4 %
Dividend Yield TTM
2.4 %
Market cap $
$ 70,497
Price / Earnings TTM
34.9
Price / Book TTM
297.4
PEG TTM
(1.4)
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
15.6 %
29.2 %
45.1 %
Free cash flow per share growth
13.2 %
16.3 %
80.5 %
Earnings per share growth
(5.5) %
(16.2) %
73 %
Business Summary:
Q&A
Contribute
By providing well-researched and detailed answer you increase your chance of becoming Top Contributor. TopFunds is free for all top contributors. Learn more
Latest Earnings Call Takeaways
2026 Q2 (Jul 31, 2026)
1) Strategy & Leadership
- Noel Wallace recognized John Faucher's contributions as he prepares for retirement after 40 quarters with the company.
- The company aims to maintain momentum in emerging markets while addressing challenges in the U.S. market.
- Focus on innovation and brand support is emphasized, particularly in premium segments and new product launches.
2) Financial & Segment Results
- Colgate-Palmolive reported strong top and bottom line growth, with free cash flow up 18% and $1.4 billion returned to shareholders.
- Organic sales growth was driven by emerging markets, particularly India, Brazil, Mexico, and China, with mid-single-digit growth reported.
- Gross margin improved by 100 basis points, aided by pricing strategies and effective revenue growth management.
| Metric | Q2 2026 Results | YoY Change |
|---|---|---|
| Free Cash Flow | Up 18% | - |
| Gross Margin | Up 100 bps | - |
| Organic Sales Growth | Mid-single digits | - |
3) Problems / Headwinds
- The U.S. market performance was below expectations, with inventory reductions from retailers impacting shipment numbers.
- Increased competition and consumer uncertainty due to inflation and geopolitical tensions are creating volatility in sales.
- The pet division faced category softness, although Hill's brand showed resilience with solid organic growth.
4) Operational or Product Plans
- Plans to scale up innovations for 2026 and 2027, including the Optic White Pro Series and Fabuloso product expansions.
- Continued investment in digital, AI, and revenue growth management to enhance product offerings and market share.
- The rollout of the Prime pet food line is being approached cautiously, focusing on building brand credibility through veterinary endorsement.
5) Guidance & Outlook / Investor Angle
- The company is optimistic about the second half of 2026, expecting a shift towards volume-driven growth and improved performance in emerging markets.
- Despite uncertainties, Colgate-Palmolive maintains a cautious outlook, with guidance reflecting potential headwinds in the U.S. market.
- The company plans to reassess organic sales growth guidance as the year progresses, considering the impact of private label exits and geopolitical factors.
Bottom line: Colgate-Palmolive's strong performance in emerging markets and effective cost management strategies position it well for future growth, despite challenges in the U.S. market. Investors should remain optimistic about the company's innovation-driven approach and commitment to brand support, although caution is warranted given the volatile operating environment.
Annual Reports, Presentations And IR Contacts
Go to the websiteColgate-Palmolive — Financial Overview, Stock Price, Market Cap
Colgate-Palmolive is a company. Founded in 1806. As of October 9, 2026, the company's market capitalization is $70496650900 with a current stock price of $88.10.
